Show simple item record

dc.contributor.authorLong, Aideen
dc.contributor.authorRon, Dorit
dc.contributor.authorAdams, David R.
dc.contributor.authorBaillie, George S.
dc.contributor.authorO'Connor, Rosemary
dc.contributor.authorKiely, Patrick A.
dc.date.accessioned2019-11-21T10:55:54Z
dc.date.available2019-11-21T10:55:54Z
dc.date.issued2013
dc.date.submitted2013en
dc.identifier.citationRon, D., Adams, D.R., Baillie, G.S., Long, A., O'Connor, R. & Kiely, P.A., RACK1 to the future--a historical perspective, 2013, Cell communication and signaling, CCS, 11, 53en
dc.identifier.issn1478-811x
dc.identifier.otherY
dc.descriptionPUBLISHEDen
dc.description.abstractThis perspective summarises the first and long overdue RACK1 meeting held at the University of Limerick, Ireland, May 2013, in which RACK1 ’ s role in the immune system, the heart and the brain were discussed and its contribution to disease states such as cancer, cardiac hypertrophy and addiction were described. RACK1 is a scaffolding protein and a member of the WD repeat family of proteins. These proteins have a unique architectural assembly that facilitates protein anchoring and the stabilisation of protein activity. A large body of evidence is accumulating which is helping to define the versatile role of RACK1 in assembling and dismantling complex signaling pathways from the cell membrane to the nucleus in health and disease. In this commentary, we first provide a historical perspective on RACK1. We also address many of the pertinent and topical questions about this protein such as its role in transcription, epigenetics and translation, its cytoskeletal contribution and the merits of targeting RACK1 in disease.en
dc.description.sponsorshipThis work was supported by grants received from; the Health Research Board of Ireland (HRB) (Knowledge Exchange and Dissemination Scheme HRB/ KEDS/HRA/2009/188 and HRA/2009/188) (P.K.), the Irish Cancer Society (P.K.), NIH/NIAAA P50 AA017072 (D.R), NIH-NIAAA R01 AA016848 (D.R) and funds from the State of California for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (D.R), MRC grant (MR/J007412/1) (G.B), the Health Research Board of Ireland (HRB) (A.L.), and the Health Research Board (HRB) and Science Foundation Ireland (SFI) (R. OC.). We are grateful to our colleagues in the Kiely and Ron Laboratories for helpful discussions and critical review.en
dc.format.extent53en
dc.language.isoenen
dc.relation.ispartofseriesCell communication and signaling : CCS;
dc.relation.ispartofseries11;
dc.relation.ispartofseries53;
dc.rightsYen
dc.subjectRACK1en
dc.subjectProtein kinaseen
dc.subject.lcshRACK1en
dc.titleRACK1 to the future – a historical perspective.en
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/longai
dc.identifier.rssinternalid183656
dc.identifier.doihttp://dx.doi.org/10.1186/1478-811x-11-53
dc.rights.ecaccessrightsopenAccess
dc.identifier.orcid_id0000-0002-9918-9960
dc.contributor.sponsorscience foundation irelanden
dc.identifier.urihttps://biosignaling.biomedcentral.com/articles/10.1186/1478-811X-11-53
dc.identifier.urihttp://hdl.handle.net/2262/90816


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record